Abstract
The title compound ([3,5-Me2bpzaH2][AuCl4]Cl, 1) (Me2bpza = bis(3,5-dimethylpyrazolyl)acetic acid), was prepared by reacting H[AuCl4] with 3,5-Me2bpza; and spectroscopically and structurally characterized. In the solid state structure of 1, the pyrazolyl ligand is doubly protonated to form two strong charge assisted hydrogen bonds of the type N+{single bond}H⋯Cl- with the single chloride anion whilst the [AuCl4]- anion remains discrete. The anti-HIV-1 activity of 1 was determined by a colorimetric direct enzyme reverse transcriptase (RT) assay and a fluorogenic protease (PR) assay. Compound 1 significantly (p < 0.05) inhibited RT over a concentration range of 5-250 μM and inhibited HIV-1 protease at 100 μM. Compound 1 inhibited two very important HIV-1 enzymes (RT and PR) in direct enzyme assays and therefore warrants further evaluation.
Original language | English |
---|---|
Pages (from-to) | 190-194 |
Number of pages | 5 |
Journal | Journal of Inorganic Biochemistry |
Volume | 103 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2009 |
Keywords
- Gold(III) compound
- HIV-1
- PR inhibition
- RT inhibition
ASJC Scopus subject areas
- Biochemistry
- Inorganic Chemistry